Repligen Q1 revenue falls 17% to $151M; GAAP EPS $0.04, adjusted EPS $0.28

REPLIGEN CORP

2024-Q1 EPS reported $0.04 revenue$151,346,000

Q1 revenue $151.3M, down from $182.7M YoY; GAAP net income $2.1M ($0.04 diluted EPS) vs $28.8M ($0.51).
Adjusted net income $15.8M ($0.28 diluted EPS) vs $36.3M ($0.64); adjusted gross margin 48.6% vs 55.2%.
New modalities revenue up 16% YoY; Filtration (non-COVID) up 12% YoY; book-to-bill 0.99 (Q1), 1.03 (nine-month).
FY2024 guidance reaffirmed: revenue $620M-$650M, adjusted EPS $1.42-$1.49, adjusted op margin 13%-14%.
Cash and investments $780.6M as of March 31, 2024; Metenova added over $5M revenue in Q1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

REPLIGEN CORP reported first quarter of 2024, covering the three-month period ended March 31, 2024 results: revenue $151.3 million, net income $2.1 million, EPS $0.04. Guidance reaffirmed.

Period: first quarter of 2024, covering the three-month period ended March 31, 2024
Revenue: $151.3 million
Net income: $2.1 million
EPS: $0.04
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453 Repligen Reports First Quarter 2024 Financial Results • Reports first quarter revenue of $151 million • Increased new modalities revenue by 16% year-over-year • Increased Filtration (non-COVID) revenue by 12% year-over-year • Achieved a nine-month book-to-bill ratio of 1.03

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-24-126349

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.